So-Young International (SY) - Multiplikator Forward P/S
So-Young International (SY) is developing a Chinese aesthetic medicine marketplace driven by a powerful network effect. Growth is based on the digitalization of clinics and AI-driven personalization, although strict government regulatory oversight is constraining expansion. The change in the projected P/S ratio visualizes market revenue expectations, while the value of 0.70 corresponds to the current metric, capturing the business's investment cycle stage.
SY (soyoung.com): rincian analitis lan laporan miturut indikator
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Total Utang marang Modal So-Young International|SY - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas So-Young International Inc.|SY - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku SoYoung|SY - Tanggungan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan So-Young International|Indikator likuiditas cepet soyoung.com
- data bathi bisnis lan rasio investasi:
SY - Bathi sawise mbayar pajeg|Proyeksi bathi mangsa ngarep So-Young International|SY - Periode bali modal bisnis|Rega marang bathi mangsa ngarep So-Young International Inc|SY - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan SoYoung|SY - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) So-Young International|SY - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan soyoung.com|SY - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep So-Young International
- indikator dodolan lan pendapatan:
Ringkesan analisis perusahaan:SY (So-Young International)
Forward P/S determines the market value of a business relative to projected revenue, allowing for an assessment of the justification for the control premium over assets. By analyzing the future P/S dynamics of So-Young International (SY), an investor can compare market expectations with the monetization of the partner clinic base, where a stable multiple confirms the efficiency of extracting profit from the platform's dominant position in the Chinese aesthetic medicine sector.
Analisis pesaing So-Young International
Rasio rega marang prakiraan pendapatan Veeva Corp VEEV|Rasio rega marang pendapatan sing dikarepake DOCS (Doximity, Inc.)|HQY: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan WAY (waystar.com)|CorVel Corp. (CRVL) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Privia Health (PRVA)|Rasio rega marang prakiraan pendapatan Huron Corp|Kapitalisasi marang prakiraan pendapatan CERT (Certara Corp)|Rasio rega marang prakiraan pendapatan Omnicell (OMCL)|GoodRx Holdings, Inc. - Kapitalisasi marang prakiraan pendapatan|Schrödinger - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Phreesia Inc (PHR)|OMDA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan EVH (Evolent Health, Inc.)|HSTM: Multiplikator Forward P/S|DH: Rasio rega marang pendapatan sing dikarepake|CCSI (Consensus) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan AGL|Multiplikator Forward P/S ABSI|NRC (National Research Corp) - Rega forward marang dodolan|Multiplikator Forward P/S SPOK (spok.com)|Rega forward marang dodolan OPRX|trubridge.com - Multiplikator Forward P/S|SLP (Simulations Plus) - Kapitalisasi marang prakiraan pendapatan|SOPHiA GENETICS SA (SOPH) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Health Catalyst, Inc.|Multiplikator forward rega marang pendapatan CCLD|researchsolutions.com (RSSS) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S DLHC|OneMedNet Corp - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S SCNX (Scienture Corp)|Rasio rega marang pendapatan sing dikarepake HCTI (Healthcare Triangle Corp)|iSpecimen Corp - Multiplikator Forward P/S|Rega forward marang dodolan BFRG (bullfrogai.com)|WORX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan MSP Recovery|Rasio rega marang prakiraan pendapatan icoreconnect.com|MEDS: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Orgenesis Inc. (ORGS)|Rasio kapitalisasi marang dodolan sing dikarepake R1 RCM, Inc.|Multiplikator Forward P/S SHCR (sharecare.com)|Rasio kapitalisasi marang dodolan sing dikarepake Streamline Health Solutions, Inc. (STRM)|SYRA - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Apollo Medical Holdings Inc. AMEH|Model N (MODN) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan NXGN
